IL-23R

IL-23R Overview

English NameInterleukin 23 ReceptorApproved Drugs1
Drugs in Clinical Trials2Target SynonymIL-23 receptor,IL23R,Interleukin 23 Receptor,Interleukin-23 Receptor,IL-23R
Highest Development StageApproved
English NameInterleukin 23 Receptor
Target SynonymIL-23 receptor,IL23R,Interleukin 23 Receptor,Interleukin-23 Receptor,IL-23R
Approved Drugs1
Drugs in Clinical Trials2
Highest Development StageApproved

Product Inquiry

IL-23R Background

Interleukin 23 receptor (IL-23R) is a type I cytokine receptor, and IL-23R pairs with the receptor molecule IL12RB1/IL12Rbeta1, and both are required for IL23A signaling. Also, IL-23R associates constitutively with Janus kinase 2 (JAK2), and binds to transcription activator STAT3 in a ligand-dependent manner. Furthermore, IL-23R mediates T-cells, NK cells and possibly certain macrophage/myeloid cells stimulation probably through activation of the Jak-Stat signaling cascade. As for IL-23, it may be responsible for autoimmune inflammatory diseases and be important for tumorigenesis.

IL-23R Synonyms

IL-23 R,IL-23 Receptor

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
BezisterimHE-3286; NE-3107Phase 3 ClinicalHarbor Therapeutics IncAlzheimer Disease; Arthritis, Rheumatoid; Brain Injuries, Traumatic; Colitis, Ulcerative; Diabetes Mellitus, Type 2; Insulin Resistance; Parkinson Disease; Post-Acute COVID-19 Syndrome
Details
PN-232PN-232; JNJ75105186Phase 1 ClinicalProtagonist Therapeutics Inc
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
IcotrokinraPN-235; JNJ-2113; JNJ-77242113-AAC; PN-21235; JNJ-77242113ApprovedProtagonist Therapeutics IncICOTYDEUnited StatesPlaque psoriasisJanssen Biotech Inc2026-03-17Arthritis, Psoriatic; Colitis, Ulcerative; Crohn Disease; Erythrodermic psoriasis; Generalised pustular psoriasis; Plaque psoriasis; Psoriasis
Details
  • Overview
  • Product Inquiry
  • Marketed Drug Information
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland